|
|
||||||||
|
© 2004 European Association of Cardio-Thoracic Surgery
A novel method of preparative myocardial protection using green tea polyphenol in oral uptakeDepartment of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan * Corresponding author. Tel.: +81-75-751-3780; fax: +81-75-751-3098. (E-mail: masakom{at}kuhp.kyoto-u.ac.jp). Received April 14, 2004; received in revised form June 16, 2004; accepted June 17, 2004
Reperfusion injury has been one of the serious problems in cardiac surgery and medicine. We report a novel method of myocardial protection. Eight SpragueDawley rats, group A, were administrated green tea polyphenol orally. Eight other rats, group B, received no medication. Isolated hearts were perfused with a Langendorff's apparatus, and reperfused after 90min arrest. The left ventricular (LV) function, size, weight and the oxidative stress spaciotemporal analysis were performed. The LV size in group B became enlarged by 1.8±0.12 (mean±SD), but in group A, the LV enlarged only 1.1±0.08 times. The heart weight ratio was lighter (1.35±0.05) in group A than in group B (1.49±0.03, P<0.05). The LV end-systolic pressure volume relationship remained higher in group A. Oxidative stress as shown by 8-hydroxy-2'-deoxyguanosine was lower in group A (81.5±11.6) than in group B (226.9±35.6, P<0.0001). Polyphenol labeled FITC was located in the cell membrane of cardiomyocite. Polyphenol can protect a heart from oxidative stress, and maintain good LV function after ischemic arrest and reperfusion. This pre-treatment by polyphenol may add further benefit to current treatments of myocardial protection.
During cardiac surgery, protection of myocardium is paramount. Myocardial protection in surgery usually consists of using cardioplegic solution or other methods. Historically, the topical cooling method was first used. Later the method of core-cooling using cold cardioplegic solution, e.g. St. Thomas Hospital's solution, was developed. Recently, many scientific reports discussed other ways to protect the heart during surgery, for example, tepid cardioplegia, blood cardioplegia, and so on. But we have not yet been able to find the completely effective way to protect hearts from the damage of ischemia and reperfusion injury [1]. Actually, we are sometimes faced with serious damages of the heart and heart function after operation because of ischemic damages or reperfusion injuries. Due to this primary concern, our team has previously focused and reported on oxidative stress sustained by the heart, specifically in the ischemic condition, and after reperfusion. We reported that oxidative stress, an important factor of reperfusion injury, continued from the peri-operative stage to the post-operative stage. Basically, oxidative stress is closely related to the balance between ischemic factors and defensive factors. We inferred that some pre-treatment to strengthen the defensive factors of the heart would be effective for myocardial protection during and after surgery. As there were only a few reports on medication or methods of myocardial protection that are used pre-operatively, we focused on the possible preventive effects of a natural compound, green tea polyphenol. Polyphenol is a natural substance found in common food. A recent study reported that polyphenol was one of the free radical scavengers, protecting cells from ischemic damages [2]. We hypothesized that polyphenol pre-treatment, administered orally prior to surgery, could protect that heart from oxidative stress after reperfusion and avoid cell edema. Therefore polyphenol could present a new method of myocardial protection. Green tea, being rich in polyphenol, was a natural choice for our study. Our hypothesis was that green tea polyphenol, which was given in pre-operative oral uptake method, could decrease heart damage and maintain heart function after ischemia and reperfusion, because we observed the green tea polyphenol protects the heart by remaining in the cell membrane of cardiomyocite. The purpose of this study was to explicate the effect of green tea polyphenol on reperfusion injury of heart and to propose the new method of heart protection.
2.1. Green tea polyphenol Polyphenol extracted from green tea was purchased from PFI Inc., Kyoto, Japan. It was composed mainly of ()-epigallo-catechin-3-O-gallate (28%), ()-gallocatechin-3-O-gallate (11.6%), ()-epicatechin-3-O-gallate (4.6%), ()-epigallocatechin (15.0%), (+)-gallocatechin (14.8%), ()-epicatechin (7.0%) and (+)-catechin (9.5%), and its purity exceeded 90%. 2.2. Models Sixteen SpragueDawley (S.D.) rats were randomized. Eight S.D. rats had 103M green tea polyphenol in oral uptake (35ml/day in average, group A) for 14 days. Eight other rats had no medication (group B). All animals in this study received human care in compliance with Principles of Laboratory Animals Care formulated by National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals prepared by Institute of Laboratory Animals Resources and published by the National Institute of Health.2.3. Heart isolation and protocol of perfusion Rats were anticoagulated with heparin (1000IU/kg i.v.). The isolated hearts were rapidly excited and perfused in a Langendorff's method at a constant pressure of 75mmHg with 37.5°C modified KrebsHenseleit solution (in millimoles per liter: NaCl, 118; KCl, 4.7; MgSO4, 1.2, KH2PO4, 1.2; NaHCO3, 25; CaCl2, 2.5; glucose, 11) and gassed with a mixture of 95% oxygen and 5% carbon dioxide.After 20min of equilibration, the hearts were arrested by 20ml/kg of St. Thomas solution. After 90min arrest with intermittent infusion of the cardioplegic solution (10ml/kg) every 30min, the hearts were reperfused. The left ventricular (LV) function was measured just before the arrest, 5 and 20min after reperfusion. At the same time, the coronary perfusion buffer was sampled from PA. After reperfusion, the hearts were evaluated with immunohistochemical studies on 8-hydroxy-2'-deoxyguanosine (8-OHdG) as an oxidative stress marker [3]. 2.4. Immunohistochemistry Cardiac tissues were fixed overnight in Bouin's solution immediately after dissection, followed by dehydration with 50 and 70% ethanol for 24h, respectively. The avidinbiotin complex method was used as previously described [3,4]. Briefly, after deparaffinization of the specimens, normal rabbit serum (diluted to 1:75; Dako, Kyoto) for the inhibition of nonspecific binding of the secondary antibody, a purified mouse monoclonal antibody against 8-OHdG (N45.1, 10µg/ml; Japan Institute for the Control of Aging, Fukuroi, Shizuoka, Japan), biotin-labeled rabbit anti-mouse IgG serum (diluted 1:100; Dako), and avidinbiotin complex (diluted 1:100; Vector Laboratories, Burlingame, CA) were sequentially applied. A substrate for alkaline phosphatase (black) was obtained from Vector.Quantification of immunohistological data (8-OHdG index) was calculated as where X is the staining density indicated in gray scale, using NIH image and Photoshop [4]. 2.5. Polyphenol-FITC Six Sprague-Dawley rats were given green tea polyphenol labeled by FITC for 14days, and detected in same methods. And the sample of heart harvested was fixed frozen and determined by UV.2.6. Statistical analysis All values are expressed as mean±SD. The statistical analysis was performed using analysis of variance (ANOVA) and Student's t-test (StatView®, SAS Institute Inc., CA). The differences were considered as statistically significant at a P-value of less than 0.05.
3.1. LV function after reperfusion ESPVR (LV end systolic pressure volume relationship) was decreased 5min after reperfusion and returned to the level of pre-ischemic level in control group. However, it was increased in polyphenol group especially 20min after reperfusion (P=0.0002) (Fig. 1).
3.2. Edema after reperfusion Heart Weight (HW 20min after reperfusion/HW just after harvest) in polyphenol group was 1.26±0.05. It was weighed less than the control group (1.49±0.09, P=0.0183). The LV size in control group became larger by 1.8±0.12 (mean±SD) times, but in polyphenol group, it enlarged only 1.1±0.08 times. In microscopic view, cystic change near nuclei of cardiomyocites was seen after the reperfusion. In polyphenol group, however, such a change was prevented (Fig. 2).
3.3. Oxidative stress 8-OHdG index was 81.5±11.6 in polyphenol group and 226.9±35.6 in control group (P<0.0001) (Fig. 3). The polyphenol group showed a low level of oxidative stress.
3.4. Location of polyphenol on myocardium Polyphenol labeled FITC was located in the cell membrane of the cardiomyocite, shown by the green line (Fig. 4).
Polyphenol is a natural substance, existing in a lot of common food such as apple juice, red wine, or green tea, and is a well known anti-oxidants [5]. Polyphenol has been reported to have several abilities of cell protection in many medical scientific fields. For example, polyphenol was reported as being able to preserve pancreatic islet long term [6]. Polyphenol is a well-known free radical scavenger [7,8]. In recent reports, polyphenol was shown to inhibit atherosclerosis [9], enhance nitric oxide release from endothelial cells [10,11], and protect against nitric oxide toxicity [12]. In the research of cardiology, Vinson reported that polyphenol has an anti-oxidative effect on heart disease [13], and Ray showed that polyphenol protects the heart from ischemia reperfusion injury [14]. According to the results of this study, polyphenol, which was given orally 14 days before the operation, was delivered and remained in the cell membrane of cardiomyocite. Our data show polyphenol bound to the cell membrane of the cardiomyocite and stayed during the ischemic phase and after reperfusion. Consequently, polyphenol protected the heart effectively from oxidative stress after reperfusion, avoided cell edema, and maintained good LV function after the ischemic arrest and reperfusion. These facts suggest that polyphenol is suitable for pre-treatment for ischemic heart condition during heart surgery. According to our knowledge, this is the first report to suggest the benefit of polyphenol, administrated pre-operatively. Previously, several methods of cardiac protection were reported; however, most of them were intra-operative methods using some drugs or cardioplegic solutions. Our method is novel because it proposed a pre-treatment method. Oral uptake is a very simple and easy method, so it may be useful in clinical treatment. With respect to pre-treatment methods, Coghlan reported the effect of allopurinol [15]. Allopurinol is one of the anti-oxidative substances, and Coghlan showed a positive effect of allopurinol on heart function after surgery in a randomized clinical study. However, compared with allopurinol, natural polyphenol, including green tea polyphenol, has some advantages. Polyphenol is basically one of the natural substances in food, and no serious side effects of polyphenol have been reported, whereas allopurinol has some side effects, e.g. headache, drowsiness and so on. Therefore, we can propose not only a medical treatment but also a dietary cure method using polyphenol. From this point of view, polyphenol offers possibilities for broad health care for heart diseases. This study was limited to Langendorff's model and therefore not equal to ischemic reperfusion in cardiac surgery. In future study, we will examine the effects of green tea polyphenol pre-treatment on larger animal model prior to a cardiopulmonary bypass. In conclusion, this novel pre-treatment method, using polyphenol orally, may improve the current method of myocardial protection in present use and improve the recovery rate for heart diseases by diminishing the oxidative stress that caused ischemic arrest and reperfusion injury.
We really appreciate Miss Mikiko Saito, the research assistant, for her help in collecting data for this study. doi:10.1016/j.icvts.2004.06.013
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |